These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
99 related items for PubMed ID: 9686954
1. Humoral factor in children with neonatal Bartter syndrome reduces bone calcium uptake in vitro. Shoemaker LR, Bergstrom W, Ragosta K, Welch TR. Pediatr Nephrol; 1998 Jun; 12(5):371-6. PubMed ID: 9686954 [Abstract] [Full Text] [Related]
2. Angiotensin II reduces calcium uptake into bone. Schurman SJ, Bergstrom WH, Shoemaker LR, Welch TR. Pediatr Nephrol; 2004 Jan; 19(1):33-5. PubMed ID: 14648327 [Abstract] [Full Text] [Related]
9. Bone mineral density and bone turnover in patients with Bartter syndrome. Rodríguez-Soriano J, Vallo A, Aguirre M. Pediatr Nephrol; 2005 Aug; 20(8):1120-5. PubMed ID: 15942790 [Abstract] [Full Text] [Related]
12. Neonatal Bartter syndrome--use of indomethacin in the newborn period and prevention of growth failure. Mackie FE, Hodson EM, Roy LP, Knight JF. Pediatr Nephrol; 1996 Dec; 10(6):756-8. PubMed ID: 8971899 [Abstract] [Full Text] [Related]
14. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis. Joseph F, Ahmad AM, Ul-Haq M, Durham BH, Whittingham P, Fraser WD, Vora JP. J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753 [Abstract] [Full Text] [Related]
15. The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat. Dick IM, St John A, Heal S, Prince RL. Calcif Tissue Int; 1996 Sep; 59(3):174-8. PubMed ID: 8694894 [Abstract] [Full Text] [Related]
16. Evidence for disturbed regulation of calciotropic hormone metabolism in gitelman syndrome. Bianchetti MG, Bettinelli A, Casez JP, Basilico E, Metta MG, Spicher I, Santeramo C, Bigoni M, Jaeger P. J Clin Endocrinol Metab; 1995 Jan; 80(1):224-8. PubMed ID: 7829616 [Abstract] [Full Text] [Related]
17. Indomethacin does not inhibit the anabolic effect of parathyroid hormone on the long bones of rats. Gera I, Hock JM, Gunness-Hey M, Fonseca J, Raisz LG. Calcif Tissue Int; 1987 Apr; 40(4):206-11. PubMed ID: 3107773 [Abstract] [Full Text] [Related]
18. Bone metabolism and mineralisation after cytotoxic chemotherapy including ifosfamide. de Schepper J, Hachimi-Idrissi S, Louis O, Maurus R, Otten J. Arch Dis Child; 1994 Oct; 71(4):346-8. PubMed ID: 7979531 [Abstract] [Full Text] [Related]
19. Calcilytic Ameliorates Abnormalities of Mutant Calcium-Sensing Receptor (CaSR) Knock-In Mice Mimicking Autosomal Dominant Hypocalcemia (ADH). Dong B, Endo I, Ohnishi Y, Kondo T, Hasegawa T, Amizuka N, Kiyonari H, Shioi G, Abe M, Fukumoto S, Matsumoto T. J Bone Miner Res; 2015 Nov; 30(11):1980-93. PubMed ID: 25967373 [Abstract] [Full Text] [Related]
20. Increased sensitivity to 1,25(OH)2D3 in bone from genetic hypercalciuric rats. Krieger NS, Stathopoulos VM, Bushinsky DA. Am J Physiol; 1996 Jul; 271(1 Pt 1):C130-5. PubMed ID: 8760038 [Abstract] [Full Text] [Related] Page: [Next] [New Search]